[LOGO]

                       N E W S   R E L E A S E


For Immediate Release

Contact:    HemaCare Corporation
            JoAnn Mannise, Director of Investor Relations
            Phone: 877-310-0717
            Email: www.hemacare.com



 HEMACARE ANNOUNCES BOARD AND CHIEF FINANCIAL OFFICER APPOINTMENTS
-----------------------------------------------------------------------

      Los Angeles, CA, November 3, 2003 - HemaCare Corporation (OTC
Bulletin Board: HEMA.OB) announced today that Steven Gerber has been
named to the Board of Directors. Dr. Gerber, a cardiologist, has
extensive expertise in the securities industry serving most recently as
the head of healthcare research at CIBC World Markets.  He was also a
member of the Board of Directors of Syncor International Corp., a
specialty health services company acquired in January 2003, by Cardinal
Health.  Dr. Gerber fills a board vacancy created by the resignation of
Steven Wallace who had been a member of the Board since 2001.

      The Company has also appointed Robert Chilton as its Chief
Financial Officer.  Mr. Chilton was the Executive Vice President and
Chief Financial Officer of Preferred Health Management, Inc., a
specialty healthcare services company. In addition, Mr. Chilton was the
CFO of OrthAlliance, Inc., an orthodontic practice management company,
during that company's successful IPO.

      Commenting on the appointments, Jay Steffenhagen, Chairman, stated
that, "Steven Gerber and Bob Chilton bring a wealth of finance and
healthcare expertise to our organization.  We are looking forward to
their contributions in shaping the future of the Company."

                      ABOUT HEMACARE CORPORATION

	Founded in 1978, HemaCare is a national provider of blood products and
services and the only publicly traded company engaged in the blood services
industry in the U.S.  HemaCare is licensed by the FDA and accredited by the
American Association of Blood Banks.  The company focuses on providing cost
effective, high quality solutions to the blood-related needs of U.S.
hospitals.

                                   - more -

 2

This press release may contain "forward-looking statements" within the
meaning of the term in the Private Securities Litigation Reform Act of 1995
(Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended).  Additional written or oral
forward-looking statements may be made by the Company from time to time in
filings with the Securities and Exchange Commission or otherwise.
Statements contained herein that are not historical facts are forward-
looking statements pursuant to the safe harbor provisions referenced
above.  Forward-looking statements are inherently subject to risks
and uncertainties some of which cannot be predicted or quantified.
Such risks and uncertainties include, without limitation, the risks
and uncertainties set forth from time to time in reports filed by the
Company with the Securities and Exchange Commission.  Although
the Company believes that the expectations reflected in such forward-looking
statements are reasonable, it can give no assurance that such expectations
will prove to be correct.  Consequently, future events and actual results
could differ materially from those set forth in, or contemplated by, the
forward-looking statements contained herein.  The Company undertakes no
obligation to publicly release any revision to these forward-looking
statements made to reflect events or circumstances after the date hereof.

                                  ###